YOLFTbeta
Lifecare AS

Lifecare AS

LIFE · OL · Healthcare / Medical Devices

0.3805NOK-0.01 (-1.68%)

Price History

Full chart

Market Stats

Previous Close0.387
Open0.3815
Day Range0.3755 – 0.39
52-Week Range0.27 – 8.02
Volume2.06M
Market Cap207.00M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.41
Dividend Yield0.00%
Beta-0.43
50-Day Avg0.3208
200-Day Avg0.4874

About

Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway and United Kingdom. The company develops Sencell, a 3D printed nano-sensor for monitoring glucose levels in patients with diabetes and for veterinary applications; as well as medical devices that remove subdermal implants. Lifecare ASA was founded in 2006 and is headquartered in Bergen, Norway.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Joacim Holter
  • Employees11
  • HeadquartersYtrebygdsvegen 215, Bergen, Norway, 5258, Norway
  • Websitehttps://lifecare.no

Leadership

  • Mr. Joacim HolterCEO & Head of Investor Relations · b. 1976
  • Mr. Petter NielsenChief Financial Officer
  • Mr. Jo Oeding AmundstadManaging Director of Lifecare Veterinary

Financials

Income Statement

Currency: NOK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.89M1.61M551.08K3.49M2.07M1.67M324.41K16.71M13.09M3.03M112.00K
Growth (%)--58.55%-65.85%+532.54%-40.65%-19.16%-80.60%+5052.25%-21.71%-76.84%-96.30%
Cost of Revenue3.89M2.35M1.50M12.02M8.51M7.25M16.83M29.04M1.53M--
Gross Profit--738.65K-944.97K-8.53M-6.44M-5.58M-16.50M-12.32M11.56M3.03M-
Gross Margin--45.77%-171.48%-244.72%-311.32%-333.41%-5086.46%-73.72%88.34%100.00%-
Operating Expense-4.24M2.47M200.00K300.00K-3.12M-570.68K4.58M46.91M87.81M-
Operating Income-7.24M-4.98M-3.42M-8.73M-6.74M-2.46M-15.93M-16.90M-35.35M-84.78M-129.96M
Operating Margin-185.84%-308.72%-620.12%-250.46%-325.82%-146.95%-4910.55%-101.14%-270.12%-2797.20%-116035.71%
EBITDA-7.48M-4.91M-3.40M-8.70M-6.54M-2.59M-15.38M-14.62M-32.10M-68.09M-110.24M
EBITDA Margin-192.14%-304.28%-617.28%-249.59%-315.92%-154.79%-4741.32%-87.47%-245.26%-2246.55%-98425.89%
Net Income-7.49M-4.99M-3.43M-8.79M-6.56M-2.74M-15.88M-17.48M-35.26M-71.76M-119.51M
Net Income Margin-192.44%-309.46%-622.56%-252.25%-316.87%-163.88%-4894.06%-104.56%-269.43%-2367.44%-106708.04%
R&D---6.90M6.30M-7.90M9.40M2.60M19.45M67.94M
R&D as % of Total Revenue---197.95%304.54%-2435.18%56.24%19.91%641.64%60664.29%
Interest Expense4.60K56.87K2.16K63.73K3614254.22K637947.47K536.00K2.52M
Interest Expense % of Total Revenue0.12%3.52%0.39%1.83%0.02%0.03%1.30%0.00%7.24%17.68%2253.57%

Balance Sheet

Currency: NOK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.27M1.86M1.19M23.42M17.49M14.61M32.22M69.97M86.39M112.59M94.65M
Total Liabilities589.82K1.01M3.54M1.18M1.76M1.28M7.98M14.72M19.94M38.62M122.67M
Total Equity1.69M848.46K-2.35M22.24M15.73M13.33M24.25M56.44M66.40M74.41M-27.22M
Cash404.43K139.28K2.49K21.33M14.59M11.48M21.04M47.63M48.35M61.62M5.65M
Total Debt-245.00K2.27M---2.70M8.29M9.37M10.86M-
Net Debt-404.43K105.72K2.27M-21.33M-14.59M-11.48M-18.34M-43.28M-38.98M-50.75M46.05M

Cash Flow

Currency: NOK2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--6.70M-6.70M-6.70M-2.80M-13.77M-17.85M-36.00M-65.54M-110.37M
Investing Cash Flow--1.74M-1.74M-1.74M-246.94K-6.94M-9.20M-1.21M-12.36M-
Financing Cash Flow-724.95K724.95K724.95K-62.76K30.28M53.63M37.93M91.16M-
Capital Expenditure007.49M7.49M7.49M7.49M5.71M1.22M12.77M6.46M
Free Cash Flow---38.00K-2.80M-21.27M-23.56M-37.22M-78.30M-116.83M
FCF to OCF----0.57%100.00%154.41%131.98%103.37%119.48%105.85%

Earnings

Report DateSep 30, 2022Dec 31, 2022May 31, 2023Aug 23, 2023Nov 14, 2023Feb 27, 2024May 8, 2024Aug 27, 2024Nov 13, 2024Feb 20, 2025May 15, 2025Aug 20, 2025Nov 13, 2025Mar 4, 2026May 18, 2026Aug 19, 2026
EPS Estimate-----1.30-1.30--0.08--------
EPS Actual-0.01-0.28-0.21-0.07-0.78-1.40-0.10-0.09-1.07-1.70-1.27-0.24-1.18-0.39-0.250.01
Surprise----40.00%-7.69%--12.50%--------
Timing---Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-----

Key Statistics & Ratios

Market Cap207.00M
Enterprise Value97.77M
Trailing P/E0.00
Forward P/E0.00
Price / Sales27.00
Price / Book2.33
EPS-0.41
Book Value0.136
Revenue (TTM)7.67M
Gross Profit (TTM)7.67M
EBITDA-113.26M
Profit Margin0.00%
Operating Margin-4906.56%
Return on Equity-208.69%
Return on Assets-101.03%
Shares Outstanding430.36M
Shares Float330.08M
Beta-0.43
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Oct 1, 20241:13
  • Feb 7, 20191:4